Skip to main content
Fig. 14 | Cancer Nanotechnology

Fig. 14

From: Delivery of melittin-loaded niosomes for breast cancer treatment: an in vitro and in vivo evaluation of anti-cancer effect

Fig. 14

Immunohistochemistry staining of P53 in mammary gland adenocarcinoma in all experimental groups. Cancer control (original magnification, ×40) (a); healthy control (original magnification, ×40) (b); melittin 3 mg/kg (original magnification, ×40) (c); melittin 6 mg/kg (original magnification, ×40) (d); melittin-loaded niosome 1.5 mg/kg (original magnification ×40) (e); melittin-loaded niosome 3 mg/kg (original magnification, ×40) (f); empty niosome 6 mg/kg (original magnification, ×40) (g)

Back to article page